ICYMI: AMERICANS NEED RELIEF FROM BIG PHARMA’S OUT-OF-CONTROL PRESCRIPTION PRICES

04-19-2021 Blog Posts

Americans Need Relief from Big Pharma’s Out-of-Control Prescription Prices Morning Consult Lauren Aronson April 19, 2021 https://morningconsult.com/opinions/americans-need-relief-from-big-pharmas-out-of-control-prescription-prices/   Earlier this month, the principal trade group representing Big Pharma launched a new branding campaign touting drug companies’ role during the pandemic. While we can all be thankful for the vaccines and treatments that save lives and support a […]

DOSE OF REALITY: BIG PHARMA’S PRICING PRACTICES DRIVE CRISIS OF AFFORDABILITY FOR AMERICA’S CANCER PATIENTS

04-15-2021 Blog Posts

Drug Companies Repeatedly Hike Prices and Set Out-of-Control Launch Prices on Oncology Medications THE PROBLEM: A CRISIS OF AFFORDABILITY The out-of-control prices set by Big Pharma on prescription drugs used to treat cancer have created a crisis of affordability — and placed breakthrough treatments out-of-reach for too many American patients. Patients and families should never […]

SECOND OPINION: DEBUNKING BIG PHARMA’S NEW BRANDING CAMPAIGN

04-15-2021 Blog Posts

PhRMA Proposals Fail to Lower Rx Prices and Instead Benefit Drug Companies and Shift Costs — While Ad Campaign Seeks to Divert Attention from Egregious Practices This week, the principal trade group for Big Pharma, the Pharmaceutical Research and Manufacturers of America (PhRMA), launched a new seven-figure ad campaign seeking to bolster the industry’s image […]

THEY SAID IT! BIG PHARMA’S PRICE HIKES, PATENT THICKETS AND ADVERTISING SPENDING TAKE CENTER STAGE DURING SENATE HEARING

03-23-2021 Blog Posts

Lawmakers Make Bipartisan Commitment to Lowering Drug Prices, Holding Drug Companies Accountable During a hearing on prescription drug prices on Tuesday before the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) Subcommittee on Primary Health and Retirement Security, lawmakers on both sides of the aisle expressed a commitment to working together to lower drug prices […]

BIG PHARMA WATCH: BIG PHARMA’S PRICE HIKES DROVE 50 PERCENT INCREASE IN MEDICARE SPENDING ON NEUROLOGIC DRUGS

03-16-2021 Blog Posts

New Study Finds Brand Name Price Increases Causing Spending Growth to Far Outpace Claims Last week, STAT News’ “Pharmalot” covered a new study that found Big Pharma’s pricing practices led to a 50 percent increase in Medicare spending on medicines used to treat neurologic conditions over a five year period — while there was only […]

ICYMI: PHARMA-BACKED REBATE RULE THE WRONG MEDICINE FOR RX PRICES

03-11-2021 Blog Posts

Pharma-Backed Rebate Rule the Wrong Medicine for Rx Prices By Lauren Aronson Morning Consult March 11, 2021 https://morningconsult.com/opinions/pharma-backed-rebate-rule-the-wrong-medicine-for-rx-prices/ The Biden Administration recently delayed a misguided policy called the Rebate Rule, which was rushed into publication by the Trump administration at the very end of its tenure. The policy is derived from Big Pharma’s blame game tactics – designed to […]

SECOND OPINION: PFIZER TALKS IMPORTANCE OF VACCINE AFFORDABILITY WHILE SIMULTANEOUSLY PLEDGING TO HIKE PRICES

03-8-2021 Blog Posts

Big Pharma CEO Says Price Should Never Be a Barrier After CFO Promised Company Would “Get More on Price” After “Pandemic Pricing Environment” In a recent interview with “Axios on HBO,” Pfizer CEO Albert Bourla expressed concern about the affordability of COVID-19 vaccines and treatments. “It will be terrible for society if price becomes an […]

DOSE OF REALITY: BIG PHARMA TO TESTIFY ON COVID-19 VACCINES AGAINST BACKDROP OF PANDEMIC PRICE HIKES AND BIG TIME PROFITS

02-22-2021 Blog Posts

Brand Name Drug Executives Should Commit to Affordable Pricing on COVID-19 Vaccines and Treatments AN OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE The U.S. House of Representatives Committee on Energy and Commerce is scheduled to hold a hearing with Big Pharma executives on Tuesday, February 23. Executives for brand name drug giants including Pfizer, Moderna, Johnson […]

BIG PHARMA WATCH: REPORT SHOWS DESPITE PANDEMIC, BIG PHARMA HAD A “TURBOCHARGED” YEAR IN 2020

02-17-2021 Blog Posts

Analysis Finds Drug Companies Posted Banner Year For Profits and Mergers While Hiking Drug Prices During Pandemic A new report on the pharmaceutical industry from research firm Evaluate Vantage lays out in detail the blockbuster year Big Pharma had in 2020, while the industry repeatedly raised prescription drug prices amid the COVID-19 pandemic. From ballooning […]

BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB, SANOFI, MERCK, ROCHE & ASTRAZENECA

02-11-2021 Blog Posts

Brand Name Pharma Companies Continue to Bring in Sky-High Profits While Hiking Prices New fourth quarter earning reports from Big Pharma giants Bristol-Myers Squibb (BMS), Sanofi, Merck, Roche and AstraZeneca demonstrate yet again that price hikes continue to support big time profits for brand name drug companies. All five drug makers reported sky-high earnings after […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.